Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (171-180 of 587) with videos related to

Pageof 59
Sort By:
Lancet (London, England)|February 26, 1977
Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term studyW Birkmayer, P Riederer, L Ambrozi, et al.
Journal of Neural Transmission. General Section|January 1, 1993
L-glutamate and L-aspartate concentrations in the developing and aging human putamen tissueM E Kornhuber, J Kornhuber, W Retz, et al.
Free Radical Research|November 8, 2001
A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivoR Harth, M Gerlach, P Riederer, et al.
Infusionstherapie Und Klinische Ernahrung|October 1, 1987
[Changes in organic acids in plasma and cerebrospinal fluid in cerebral infarct]W D Rausch, K Schnecker, J Bruck, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Neurochemical perspectives to the function of monoamine oxidaseP Riederer, C Konradi, G Hebenstreit, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studiesP Riederer, M B Youdim, W Birkmayer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004
Dopamine receptor agonists in the therapy of Parkinson's diseaseP Foley, M Gerlach, K L Double, et al.
Annals of the New York Academy of Sciences|February 15, 2000
A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's diseaseL Frölich, D Blum-Degen, P Riederer, et al.
Parkinsonism & Related Disorders|July 2, 2008
MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?P Foley, M Gerlach, M B Youdim, et al.
Wiener Medizinische Wochenschrift (1946)|May 23, 1975
[Biochemical findings in the brain in endogenous depression]V E Neumayer, P Riederer, W Danielczyk, et al.
Pageof 59

Showing results (171-180 of 587) with videos related to

Sort By:
Pageof 59
Lancet (London, England)|February 26, 1977
Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term studyW Birkmayer, P Riederer, L Ambrozi, et al.
Journal of Neural Transmission. General Section|January 1, 1993
L-glutamate and L-aspartate concentrations in the developing and aging human putamen tissueM E Kornhuber, J Kornhuber, W Retz, et al.
Free Radical Research|November 8, 2001
A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivoR Harth, M Gerlach, P Riederer, et al.
Infusionstherapie Und Klinische Ernahrung|October 1, 1987
[Changes in organic acids in plasma and cerebrospinal fluid in cerebral infarct]W D Rausch, K Schnecker, J Bruck, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Neurochemical perspectives to the function of monoamine oxidaseP Riederer, C Konradi, G Hebenstreit, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studiesP Riederer, M B Youdim, W Birkmayer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004
Dopamine receptor agonists in the therapy of Parkinson's diseaseP Foley, M Gerlach, K L Double, et al.
Annals of the New York Academy of Sciences|February 15, 2000
A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's diseaseL Frölich, D Blum-Degen, P Riederer, et al.
Parkinsonism & Related Disorders|July 2, 2008
MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?P Foley, M Gerlach, M B Youdim, et al.
Wiener Medizinische Wochenschrift (1946)|May 23, 1975
[Biochemical findings in the brain in endogenous depression]V E Neumayer, P Riederer, W Danielczyk, et al.
Pageof 59